Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
Marc van der Valk(Academic Medical Center), Peter Reiss(Amsterdam Institute for Global Health and Development), Christine Katlama(Université Paris Cité), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Marshall J. Glesby, Robert L. Murphy(Center for Global Health), Frank van Leth(Amsterdam Institute for Global Health and Development), Rebecca K. Stellato(University Medical Center Utrecht), John J.P. Kastelein(QRx Pharma (United States)), Henri O.F. Molhuizen(Leiden University Medical Center), Andrej Horban(Universitat Autònoma de Barcelona), Georg M. N. Behrens(Medizinische Hochschule Hannover)
Cited by 255
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
|Nature Genetics|1999|1.7k